The electrocardiogram (ECG) remains a cornerstone in cardiovascular diagnostics, yet its clinical utility is often compromised by signal distortions introduced during acquisition. Contemporary ...
As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...
A new Concordia study published in npj Biomedical Innovations suggests that a simple 30-second electrocardiogram (ECG) ...
HeartBeam's 1st synthesized 12-lead ECG cleared by FDA, enabling cable-free at-home arrhythmia assessment with launch set for 2026.
Samsung Galaxy smartwatches could benefit from continuous monitoring for heart conditions, judging by a new patent filing from the tech giant. While current devices like the Galaxy Watch 6 enable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback